Form 4: RxSight Director Tamara Fountain Acquires Shares

Director Tamara Fountain acquired 37,037 shares of common stock in RxSight, Inc. on June 17, 2026, as detailed in a Form 4 filing.

Summary

• Tamara Fountain, a Director at RxSight, Inc., acquired 37,037 shares of the company's common stock on June 17, 2026.
• This acquisition brings her total beneficial ownership of common stock to 72,582 shares.
• The shares were acquired under a restricted stock unit (RSU) award, which vests one year from the grant date or at the next annual stockholder meeting, provided Fountain remains an Outside Director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard equity award to a director rather than a significant open market purchase or sale.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The RSU award structure incentivizes continued service as an Outside Director.

Risks

• The vesting of the acquired shares is contingent upon the reporting person's continued service as an Outside Director.
• Potential for future sales of these shares upon vesting, which could impact stock price.

Future Outlook

The restricted stock units acquired by Tamara Fountain are subject to vesting conditions tied to her continued service as an Outside Director, with full vesting occurring one year from the grant date or at the next annual stockholder meeting.

Industry Context

StockSavvy.ai notes that insider transactions, such as director share acquisitions, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance within the medical device sector.

Corporate Governance

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively, suggesting internal confidence, but the vesting schedule means the shares are not yet fully controlled by the director.
• Employees: The RSU grant aligns director incentives with long-term company performance, potentially benefiting employees through sustained company growth.
• Management: Reinforces the company's practice of compensating directors with equity, aligning their interests with shareholders.

Next Steps

• Tamara Fountain will continue to serve as an Outside Director, subject to the terms of the RSU award.
• The RSUs will vest on the earlier of June 17, 2027, or the date of the next annual stockholder meeting following June 17, 2026.

Key Dates

Keywords

RxSight Inc, RXST, Form 4, Insider Trading, Director Acquisition, Restricted Stock Units, Common Stock, Beneficial Ownership